TY - JOUR AU - Gandaglia, Giorgio AU - Barletta, Francesco AU - Scuderi, Simone AU - Scilipoti, Pietro AU - Rajwa, Pawel AU - Huebner, Nicolai A AU - Gomez Rivas, Juan AU - Ibanez, Laura AU - Soeterik, Timo F W AU - Bianchi, Lorenzo AU - Mattei, Agostino AU - Kesch, Claudia AU - Darr, Christopher AU - Guo, Hongqian AU - Zhuang, Junlong AU - Zattoni, Fabio AU - Fendler, Wolfgang P AU - Marra, Giancarlo AU - Stabile, Armando AU - Robesti, Daniele AU - Amparore, Daniele AU - Joniau, Steven AU - Schiavina, Riccardo AU - Sierra, Jesus Moreno AU - Porpiglia, Francesco AU - Picchio, Maria AU - Chiti, Arturo AU - Mottrie, Alexandre AU - van den Bergh, Roderick C N AU - Shariat, Shahrokh F AU - Montorsi, Francesco AU - Briganti, Alberto TI - External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. JO - European urology oncology VL - nn SN - 2588-9311 CY - Amsterdam PB - Elsevier M1 - DKFZ-2025-00277 SP - nn PY - 2025 N1 - epub AB - Extended pelvic lymph node dissection (ePLND) is recommended in selected radical prostatectomy (RP) prostate cancer (PCa) patients for staging purposes. We aim to externally validate available tools to predict lymph node invasion (LNI) in men with negative preoperative prostate-specific membrane antigen positron emission tomography (miN0).Overall, 282 intermediate- to high-risk PCa patients with miN0 disease undergoing RP and ePLND at ten centers between 2016 and 2023 were identified. The Memorial Sloan Kettering Cancer Center (MSKCC); Amsterdam-Brisbane-Sydney; and Briganti 2017, 2019, and 2023 tools predicting LNI were validated externally using calibration plots, C-indexes, and decision-curve analyses to assess calibration, discrimination, and net benefit.Overall, 36 (13 KW - Lymph node invasion (Other) KW - Magnetic resonance imaging–targeted biopsy (Other) KW - Nomogram (Other) KW - Pelvic lymph node dissection (Other) KW - Prostate cancer (Other) KW - Prostate-specific membrane antigen positron emission tomography (Other) KW - Radical prostatectomy (Other) LB - PUB:(DE-HGF)16 C6 - pmid:39890547 DO - DOI:10.1016/j.euo.2025.01.004 UR - https://inrepo02.dkfz.de/record/298421 ER -